Journey Medical Statistics
Total Valuation
Journey Medical has a market cap or net worth of $259.73 million. The enterprise value is $268.57 million.
Important Dates
The next estimated earnings date is Wednesday, March 25, 2026, after market close.
| Earnings Date | Mar 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Journey Medical has 33.26 million shares outstanding. The number of shares has increased by 16.55% in one year.
| Current Share Class | 27.26M |
| Shares Outstanding | 33.26M |
| Shares Change (YoY) | +16.55% |
| Shares Change (QoQ) | +7.16% |
| Owned by Insiders (%) | 9.40% |
| Owned by Institutions (%) | 33.67% |
| Float | 20.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 69.42 |
| PS Ratio | 4.52 |
| Forward PS | 2.82 |
| PB Ratio | 8.24 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.98.
| Current Ratio | 1.42 |
| Quick Ratio | 1.08 |
| Debt / Equity | 0.98 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.53 |
Financial Efficiency
Return on equity (ROE) is -47.05% and return on invested capital (ROIC) is -21.77%.
| Return on Equity (ROE) | -47.05% |
| Return on Assets (ROA) | -4.60% |
| Return on Invested Capital (ROIC) | -21.77% |
| Return on Capital Employed (ROCE) | -12.08% |
| Weighted Average Cost of Capital (WACC) | 8.97% |
| Revenue Per Employee | $1.45M |
| Profits Per Employee | -$211,293 |
| Employee Count | 41 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 1.71 |
Taxes
In the past 12 months, Journey Medical has paid $121,000 in taxes.
| Income Tax | 121,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.72% in the last 52 weeks. The beta is 0.82, so Journey Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | +38.72% |
| 50-Day Moving Average | 8.13 |
| 200-Day Moving Average | 7.61 |
| Relative Strength Index (RSI) | 40.27 |
| Average Volume (20 Days) | 109,559 |
Short Selling Information
The latest short interest is 2.57 million, so 7.74% of the outstanding shares have been sold short.
| Short Interest | 2.57M |
| Short Previous Month | 2.56M |
| Short % of Shares Out | 7.74% |
| Short % of Float | 12.39% |
| Short Ratio (days to cover) | 20.27 |
Income Statement
In the last 12 months, Journey Medical had revenue of $59.40 million and -$8.66 million in losses. Loss per share was -$0.38.
| Revenue | 59.40M |
| Gross Profit | 39.24M |
| Operating Income | -5.50M |
| Pretax Income | -8.54M |
| Net Income | -8.66M |
| EBITDA | -1.32M |
| EBIT | -5.50M |
| Loss Per Share | -$0.38 |
Full Income StatementBalance Sheet
The company has $24.95 million in cash and $25.30 million in debt, with a net cash position of -$353,000 or -$0.01 per share.
| Cash & Cash Equivalents | 24.95M |
| Total Debt | 25.30M |
| Net Cash | -353,000 |
| Net Cash Per Share | -$0.01 |
| Equity (Book Value) | 25.90M |
| Book Value Per Share | 0.98 |
| Working Capital | 16.67M |
Full Balance SheetCash Flow
| Operating Cash Flow | -3.93M |
| Capital Expenditures | n/a |
| Free Cash Flow | -3.93M |
| FCF Per Share | -$0.12 |
Full Cash Flow StatementMargins
Gross margin is 66.05%, with operating and profit margins of -9.25% and -14.58%.
| Gross Margin | 66.05% |
| Operating Margin | -9.25% |
| Pretax Margin | -14.38% |
| Profit Margin | -14.58% |
| EBITDA Margin | -2.22% |
| EBIT Margin | -9.25% |
| FCF Margin | n/a |
Dividends & Yields
Journey Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.55% |
| Shareholder Yield | -16.55% |
| Earnings Yield | -3.23% |
| FCF Yield | -1.47% |
Analyst Forecast
The average price target for Journey Medical is $12.67, which is 62.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.67 |
| Price Target Difference | 62.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Journey Medical has an Altman Z-Score of 0.53 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.53 |
| Piotroski F-Score | 3 |
